Outsource API manufacturing to India for lower costs, GMP-compliant quality, scalable production, and faster time-to-market ...
Construction is scheduled to commence in spring 2026, with both facilities anticipated to be fully operational by 2029.
AbbVie invests $380 million to build two new API manufacturing facilities in North Chicago while Bora Pharmaceuticals Co., ...
Feb 23 (Reuters) - AbbVie on Monday said it would invest $380 million to build two new active pharmaceutical ingredient ...
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
With SGP.32-compliant bootstrap provisioning at the factory, emnify embeds connectivity directly into the manufacturing process. Devices leave production ready to connect immediately upon first ...
Beam pumping units remain essential to onshore oil production, particularly in mature fields where artificial lift systems ...
How integrated pharmaceutical manufacturing helps CDMOs simplify scale-up, reduce complexity, and move from raw materials to ...
AbbVie (NYSE: ABBV) today announced a new $380 million investment to build two new active pharmaceutical ingredient (API) ...
As organisations accelerate digital onboarding and automated compliance processes, the security and reliability of ...
Uses Vite and Claude to sidestep Vercel lock-in A Cloudflare engineer says he has implemented 94 percent of the Next.js API ...